LIQUIDITY ALERT: Jazz Pharmceuticals’ Current Deficit Up 39.8%

Subscribe
TOPICS: Drugs/Pharmaceuticals | Earnings | Health Care | Legal Issues, Litigation | Loans & Financing | SEC-Qtrly, Annual Reports | Securities & Exch Comm, US
LOCATIONS: California | United States